Abstract
The aim of the study was to determine the level of antibodies against hemagglutinin of influenza viruses in the sera of 1,050 patients stratified into 7 different age groups during the 2016/2017 epidemic season in Poland. The method consisted of using the hemagglutination inhibition test (HAI). The findings confirmed the presence of anti-hemagglutinin antibodies against the following influenza virus antigens: A/California/7/2009 (H1N1) pdm09, A/Hong Kong/4801/2014 (H3N2), and B/Brisbane/60/2008. The level of anti-hemagglutinin antibodies differed across the age groups investigated, with the highest values in patients aged 10–14 years. We also found that the protection factor was highest for B/Brisbane/60/2008 antigen. It amounted to 72.7% in 10–14-year olds and to 69.3% in both 15–25 and 26–44-year olds. Taking into account a dismally low percentage of vaccinated population in the 2016/2017 epidemic season in Poland, amounting to barely 3.33%, the findings should be interpreted as representing the patients’ immune system response to influenza virus infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACIP (2016) Advisory Committee on Immunization Practices. Centers for Disease Control and Prevntion (CDC). Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices – United States, 2016–17 influenza season. MMWR 65(5):1–54. https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html. Accessed 18 Apr 2018
Brydak LB (2008) Influenza, pandemic flu, myth or real threat? Rytm Publishers, Warsaw (in Polish)
Brydak LB, Machała M, Myśliwska J, Myśliwski A, Trzonkowski P (2003) Immune response to influenza vaccination in an elderly population. J Clin Immunol 23(3):214–212
ECDC (2017) European Center for Disease Prevention and Control. Risk assessment of seasonal influenza, EU/EEA, 2016-2017 – Update, 25 January 2017, Stockholm; https://ecdc.europa.eu/en/publications-data/risk-assessment-update-seasonal-influenza-eueea-2016-2017. Accessed 18 Apr 2018
Kowalczyk D, Szymański K, Cieślak K, Brydak LB (2017) Serological characteristic of antibodies against hemagglutinin of influenza viruses circulated in 2014–2015 epidemic season in Poland. Adv Exp Med Biol 968:35–40
NIPH-NIH Report (2017) Epimeld. Influenza and influenza-like illness http://wwwold.pzh.gov.pl/oldpage/epimeld/grypa/index.htm. Accessed 24 July 2017
WHO (2011) Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva, Switzerland; http://hqlibdoc.who.int/publications/2011/9789241548090_eng.pdf. Accessed 20 July 2017
WHO (2015) Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season; http://www.who.int/influenza/vaccines/virus/recommendations/2014_15_north/en/. Accessed 27 July 2017
WHO (2016) Recommended composition of influenza virus vaccines for use in the 2016–2017 Northern Hemisphere influenza season. http://www.who.int/influenza/vaccines/virus/recommendations/2016_17_north/en/. Accessed 27 July 2017
Acknowledgments
Funded by NIPH-NIH thematic subject 3/EM. The authors acknowledge physicians and employees of VSESs participating in the sentinel and non-sentinel programs for their input into the influenza surveillance in Poland. We also thank the Malec Co for providing fertilized chicken embryos.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Hallmann-Szelińska, E., Cieślak, K., Kowalczyk, D., Szymański, K., Brydak, L.B. (2018). Antibodies to Influenza Virus Hemagglutinin in the 2016/2017 Epidemic Season in Poland. In: Pokorski, M. (eds) Current Trends in Immunity and Respiratory Infections. Advances in Experimental Medicine and Biology(), vol 1108. Springer, Cham. https://doi.org/10.1007/5584_2018_232
Download citation
DOI: https://doi.org/10.1007/5584_2018_232
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01634-0
Online ISBN: 978-3-030-01635-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)